Transcatheter Arterial chemoembolization for liver cancer: Is it time to distinguish conventional from drug-eluting chemoembolization?

CardioVascular and Interventional Radiology

Volumn 34, Issue 1, 2011, Pages 37-49

  Liapi, Eleni ^a   Geschwind, Jean Francois H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemoembolization; Interventional radiology; Liver cancer

Indexed keywords

CISPLATIN; DOXORUBICIN; GELFOAM; GEMCITABINE; IODINATED POPPYSEED OIL; MICROSPHERE; MITOMYCIN C; POLYVINYL ALCOHOL;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ANGIOGENESIS; ARTERY DISSECTION; BACTERIAL PERITONITIS; BILE DUCT CARCINOMA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHOLECYSTITIS; COLORECTAL CANCER; DRUG FATALITY; ESOPHAGUS VARICES BLEEDING; FEVER; GASTRIC ULCER BLEEDING; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFARCTION; INFECTION; LIVER ABSCESS; LIVER CANCER; LIVER FAILURE; LIVER FUNCTION; LIVER METASTASIS; LOADING DRUG DOSE; NAUSEA; PANCREATITIS; PATIENT SAFETY; PATIENT SELECTION; PLEURA EFFUSION; PRIORITY JOURNAL; REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VOMITING;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOEMBOLIZATION, THERAPEUTIC; DRUG DELIVERY SYSTEMS; HUMANS; LIVER NEOPLASMS; MICROSPHERES; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT SELECTION; RADIOGRAPHY, INTERVENTIONAL;

EID: 79251599283     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-010-0012-y     Document Type: Review

References (78)

1. A Roche B Girish T de Baere, et al. 2003 Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors Eur Radiol 13 136 12541121
2. K Stuart 2003 Chemoembolization in the management of liver tumors Oncologist 8 425 437 10.1634/theoncologist.8-5-425 14530495 (Pubitemid 37238870)
3. JFH Geschwind 2002 Chemoembolization for hepatocellular carcinoma: where does the truth lie? J Vasc Interv Radiol 13 991 994 10.1016/S1051-0443(07)61862- 4 12397119
4. T Aoki H Imamura K Hasegawa, et al. 2004 Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma Arch Surg 139 766 774 10.1001/archsurg.139.7.766 15249411 (Pubitemid 38886514)
5. S Arii Y Yamaoka S Futagawa, et al. 2000 Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan Hepatology 32 1224 1229 1:STN:280:DC%2BD3M%2FntFegsQ%3D%3D 10.1053/jhep.2000. 20456 11093728
6. T Livraghi F Meloni A Morabito, et al. 2004 Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center Liver Transpl 10 2 suppl 1 S98 S106 10.1002/lt.20053 14762848
7. ZW Peng MS Chen HH Liang, et al. 2010 A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma Eur J Surg Oncol 36 257 263 19643561
8. T Shibata H Isoda Y Hirokawa, et al. 2009 Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology 252 905 913 10.1148/radiol.2523081676 19567647
9. M Varela MI Real M Burrel, et al. 2007 Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics J Hepatol 46 474 481 1:CAS:528:DC%2BD2sXhtlCmtb0%3D 10.1016/j.jhep.2006.10.020 17239480 (Pubitemid 46201723)
10. A Veltri P Moretto A Doriguzzi, et al. 2006 Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC) Eur Radiol 16 661 669 10.1007/s00330-005-0029-9 16228211 (Pubitemid 44149378)
11. I Burger K Hong R Schulick, et al. 2005 Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution J Vasc Interv Radiol 16 353 361 15758131
12. M Buijs IR Kamel JA Vossen, et al. 2007 Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging J Vasc Interv Radiol 18 957 963 10.1016/j.jvir.2007.04.025 17675611 (Pubitemid 47126311)
13. E Liapi JF Geschwind JA Vossen, et al. 2008 Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization AJR Am J Roentgenol 190 67 73 10.2214/AJR.07.2550 18094295
14. TJ Vogl T Gruber JO Balzer, et al. 2009 Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study Radiology 250 281 289 10.1148/radiol.2501080295 19092099
15. TJ Vogl NN Naguib NE Nour-Eldin, et al. 2010 Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer Eur Radiol 20 173 180 10.1007/s00330-009-1525-0 19657653
16. JA Vossen IR Kamel M Buijs, et al. 2008 Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization J Comput Assist Tomogr 32 3 347 352 10.1097/RCT. 0b013e318134ecd6 18520535
17. C Aliberti M Tilli G Benea G Fiorentini 2006 Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results Anticancer Res 26 5B 3793 3795 1:STN:280:DC%2BD28nlvF2mtw%3D%3D 17094403
18. T de Baere F Deschamps C Teriitheau, et al. 2008 Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results J Vasc Interv Radiol 19 855 861 10.1016/j.jvir.2008.01.030 18503899
19. A Forner C Ayuso M Varela, et al. 2009 Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer 115 616 623 10.1002/cncr.24050 19117042
20. J Lammer K Malagari T Vogl, et al. 2009 Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study Cardiovasc Intervent Radiol 33 1 41 52 10.1007/s00270-009-9711-7 19908093
21. K Malagari K Chatzimichael E Alexopoulou, et al. 2008 Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients Cardiovasc Intervent Radiol 31 269 280 10.1007/s00270-007-9226-z 17999110
22. RC Martin K Robbins D Tomalty, et al. 2009 Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report World J Surg Oncol 7 80 10.1186/1477-7819-7-80 19886993
23. DK Reyes JA Vossen IR Kamel, et al. 2009 Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States Cancer J 15 526 532 1:CAS:528:DC%2BC3cXhslWgtr0%3D 10.1097/PPO.0b013e3181c5214b 20010173
24. CS Georgiades E Liapi C Frangakis, et al. 2006 Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization J Vasc Interv Radiol 17 1619 1624 10.1097/01.RVI.0000236608.91960.34 17057003
25. TI Huo PC Lee YH Huang, et al. 2006 The sequential changes of the model for end-stage liver disease score correlate with the severity of liver cirrhosis in patients with hepatocellular carcinoma undergoing locoregional therapy J Clin Gastroenterol 40 543 550 10.1097/00004836-200607000-00014 16825938
26. CS Georgiades K Hong D'Angelo, et al. 2005 Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis J Vasc Interv Radiol 16 1653 1659 16371532
27. Okamura J, Kawai S, Ogawa M et al.(1992) Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma: a comparison of L-TAE with Farmorubicin and L-TAE with Adriamycin (second cooperative study). Cancer Chemother Pharmacol (Historical Archive) 31:S20
28. JF Geschwind DE Ramsey BC van der Wal, et al. 2003 Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency Cardiovasc Intervent Radiol 26 111 117 10.1007/s00270-002-2524-6 12616414
29. S Bhattacharya AP Dhillon MC Winslet, et al. 1996 Human liver cancer cells and endothelial cells incorporate iodised oil Br J Cancer 73 877 881 1:CAS:528:DyaK28XislKqs70%3D 8611399
30. S Bhattacharya JR Novell MC Winslet KE Hobbs 1994 Iodized oil in the treatment of hepatocellular carcinoma Br J Surg 81 1563 1571 1:STN:280:DyaK2M7ivVKkuw%3D%3D 10.1002/bjs.1800811105 7827876
31. N Terayama O Matsui T Gabata, et al. 2001 Accumulation of iodized oil within the nonneoplastic liver adjacent to hepatocellular carcinoma via the drainage routes of the tumor after transcatheter arterial embolization Cardiovasc Intervent Radiol 24 383 387 1:STN:280:DC%2BD387otVShtQ%3D%3D 10.1007/s00270-001-0070-2 11907744
32. T Tancredi PA McCuskey Z Kan, et al. 1999 Changes in rat liver microcirculation after experimental hepatic arterial embolization: comparison of different embolic agents Radiology 211 177 181 1:STN:280:DyaK1M3gsFCltA%3D%3D 10189468
33. JW Chung JH Park JK Han, et al. 1996 Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization Radiology 198 33 40 1:STN:280:DyaK287itlWguw%3D%3D 8539401
34. HY Cheng Y Shou X Wang, et al. 2004 Adjustment of lipiodol dose according to tumor blood supply during transcatheter arterial chemoembolization for large hepatocellular carcinoma by multidetector helical CT World J Gastroenterol 10 2753 2755 15309735
35. L Mondazzi R Bottelli G Brambilla, et al. 1994 Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors Hepatology 19 1115 1123 1:STN:280: DyaK2c3ivFOnsQ%3D%3D 10.1002/hep.1840190508 7513677
36. N Nakao H Uchida K Kamino, et al. 1992 Effectiveness of lipiodol in transcatheter arterial embolization of hepatocellular carcinoma Cancer Chemother Pharmacol 31 suppl S72 S76 10.1007/BF00687110 1333913
37. SM Tadavarthy L Knight TW Ovitt, et al. 1974 Therapeutic transcatheter arterial embolization Radiology 112 13 16 1:STN:280:DyaE2c7nslSgtA%3D%3D 4545553
38. DP Link JD Strandberg R Virmani, et al. 1996 Histopathologic appearance of arterial occlusions with hydrogel and polyvinyl alcohol embolic material in domestic swine J Vasc Interv Radiol 7 897 905 1:STN:280:DyaK2s7gvFCkug%3D%3D 10.1016/S1051-0443(96)70868-0 8951758
39. K Hong H Kobeiter CS Georgiades, et al. 2005 Effects of the type of embolization particles on carboplatin concentration in liver tumors after transcatheter arterial chemoembolization in a rabbit model of liver cancer J Vasc Interv Radiol 16 1711 1717 16371540
40. A Laurent 2007 Microspheres and nonspherical particles for embolization Tech Vasc Interv Radiol 10 248 256 1:STN:280:DC%2BD1crhs1Kntw%3D%3D 10.1053/j.tvir.2008.03.010 18572137
41. J-N Vallee D Lo R Guillevin, et al. 2003 In vitro study of the compatibility of tris-acryl gelatin microspheres with various chemotherapeutic agents J Vasc Interv Radiol 14 621 628 12761316
42. GP Siskin K Dowling R Virmani, et al. 2003 Pathologic evaluation of a spherical polyvinyl alcohol embolic agent in a porcine renal model J Vasc Interv Radiol 14 89 98 12525592
43. AL Lewis MV Gonzalez AW Lloyd, et al. 2006 DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization J Vasc Interv Radiol 17 335 342 10.1097/01.RVI.0000195323.46152.B3 16517780
44. A Lewis M Gonzalez S Leppard, et al. 2007 Doxorubicin eluting beads. 1. Effects of drug loading on bead characteristics and drug distribution J Mater Sci Mater Med 18 1691 1699 1:CAS:528:DC%2BD2sXos1Cgu7o%3D 10.1007/s10856-007- 3068-8 17483878
45. AL Lewis RR Taylor B Hall, et al. 2006 Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization J Vasc Interv Radiol 17 1335 1343 10.1097/01.RVI.0000228416.21560.7F 16923981
46. Y Tang RR Taylor MV Gonzalez, et al. 2006 Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases J Controlled Release 116 e55 e56 1:STN:280:DC%2BD2srgtV2htw%3D%3D 10.1016/j.jconrel.2006.09.047
47. RR Taylor Y Tang MV Gonzalez, et al. 2007 Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties Eur J Pharmaceut Sci 30 7 14 1:CAS:528:DC%2BD28XhtlalsbnP 10.1016/j.ejps.2006.09.002
48. E de Luis J Bilbao J de Ciércoles, et al. 2008 In vivo evaluation of a new embolic spherical particle (hepasphere) in a kidney animal model Cardiovasc Intervent Radiol 31 2 367 376 10.1007/s00270-007-9240-1 18167024
49. K Malagari E Alexopoulou K Chatzimichail, et al. 2008 Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead Abdom Imaging 33 512 519 10.1007/s00261-007-9334-x 17938995
50. RT Poon WK Tso RW Pang, et al. 2007 A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead Clin Gastroenterol Hepatol 5 1100 1108 1:CAS:528: DC%2BD2sXhtFKrt7%2FE 10.1016/j.cgh.2007.04.021 17627902
51. HJ Jaeger UM Mehring F Castaneda, et al. 1996 Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma Cardiovasc Intervent Radiol 19 388 396 1:STN:280:DyaK2s7kvVSksw%3D%3D 10.1007/BF02577625 8994703
52. E Liapi CC Georgiades K Hong, et al. 2007 Transcatheter arterial chemoembolization: current technique and future promise Tech Vasc Interv Radiol 10 2 11 10.1053/j.tvir.2007.08.008 17980314
53. Geschwind JF, Khwaja A, Hong K (2005) New intraarterial drug delivery system: pharmacokinetics and tumor response in an animal model of liver cancer. In: 2005 ASCO annual meeting, Orlando, FL
54. DA Leung JE Goin C Sickles, et al. 2001 Determinants of postembolization syndrome after hepatic chemoembolization J Vasc Interv Radiol 12 321 326 1:STN:280:DC%2BD3M3gvVSnsQ%3D%3D 10.1016/S1051-0443(07)61911-3 11287509
55. Brown KT (2004) fatal pulmonary complications after arterial embolization with 40-120-μm tris-acryl gelatin microspheres. J Vasc Interv Radiol 15(2 Part 1):197-200
56. Miyayama S, Yamashiro M, Okuda M et al.(2010) Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol. doi: 10.1007/s00270-009-9781-6
57. KM Yoo BG Yoo KS Kim, et al. 2004 Cerebral lipiodol embolism during transcatheter arterial chemoembolization Neurology 63 181 183 1:STN:280:DC%2BD2czks1OjsA%3D%3D 15249637
58. J Bruix JM Llovet A Castells, et al. 1998 Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution Hepatology (Baltimore) 27 1578 1583 1:STN:280:DyaK1c3otFKnsg%3D%3D
59. JM Llovet MI Real X Montana, et al. 2002 Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 9319 1734 1739 10.1016/S0140-6736(02)08649-X 12049862
60. CM Lo H Ngan WK Tso, et al. 2002 Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 1164 1171 1:CAS:528:DC%2BD38XktF2hu7w%3D 10.1053/jhep.2002.33156 11981766
61. K Takayasu S Arii I Ikai, et al. 2006 Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients Gastroenterology 131 461 469 1:CAS:528:DC%2BD28XpsFyks7Y%3D 10.1053/j.gastro.2006.05.021 16890600
62. K Hong E Liapi CS Georgiades JF Geschwind 2005 Case-controlled comparison of a percutaneous collagen arteriotomy closure device versus manual compression after liver chemoembolization J Vasc Interv Radiol 16 339 345 1:CAS:528:DC%2BD2MXhtVKqtrzM 15758129
63. E Liapi JF Geschwind 2007 Transcatheter and ablative therapeutic approaches for solid malignancies J Clin Oncol 25 978 986 10.1200/JCO.2006.09. 8657 17350947
64. E Liapi KH Lee CC Georgiades, et al. 2007 Drug-eluting particles for interventional pharmacology Tech Vasc Interv Radiol 10 261 269 10.1053/j.tvir.2008.03.003 18572139
65. S Gupta MM Johnson R Murthy, et al. 2005 Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival Cancer 104 1590 1602 10.1002/cncr.21389 16134179
66. TJ Vogl T Gruber NN Naguib, et al. 2009 Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols AJR Am J Roentgenol 193 941 947 10.2214/AJR.08.1879 19770314
67. TJ Vogl NN Naguib S Zangos, et al. 2009 Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation Eur J Radiol 72 517 528 10.1016/j.ejrad.2008.08.008 18829195
68. C Tellez AB Benson III MT Lyster, et al. 1998 Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature Cancer 82 1250 1259 1:CAS:528: DyaK1cXitlWltbg%3D 10.1002/(SICI)1097-0142(19980401)82:7<1250::AID- CNCR7>3.0.CO;2-J 9529016
69. Geschwind J, Hong K, Georgiades C (2006) Utility of transcatheter arterial chemoembolization for liver dominant colorectal metastatic adenocarcinoma in the salvage setting. In: American Society of Clinical Oncology gastrointestinal cancers symposium, San Francisco, CA, 26-28 January 2006
70. MF Giroux RA Baum MC Soulen 2004 Chemoembolization of liver metastasis from breast carcinoma J Vasc Interv Radiol 15 289 291 15028815
71. DK Rajan MC Soulen TW Clark, et al. 2001 Sarcomas metastatic to the liver: response and survival after cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol chemoembolization J Vasc Interv Radiol 12 2 187 193 1:STN:280:DC%2BD3M7msVertw%3D%3D 10.1016/S1051-0443(07)61824-7 11265882
72. KH Lee E Liapi VP Ventura, et al. 2008 Evaluation of different calibrated spherical polyvinyl alcohol microspheres in transcatheter arterial chemoembolization: VX2 tumor model in rabbit liver J Vasc Interv Radiol 19 1065 1069 10.1016/j.jvir.2008.02.023 18589321
73. Saluzzo CM, Vignali C, Nicolini A et al.(2007) TACE with HepaSphere microspheres loaded with chemotherapeutic agent: early experience in Italy of a multi-centre study. In: WCIO 2007, Washington, DC
74. M Grosso C Vignali P Quaretti, et al. 2008 Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study Cardiovasc Intervent Radiol 31 1141 1149 10.1007/s00270-008-9409-2 18696150
75. C Camma F Schepis A Orlando, et al. 2002 Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 47 54 10.1148/radiol.2241011262 12091661
76. MF Yuen AOO Chan BCY Wong, et al. 2003 Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients Am J Gastroenterol 98 1181 1185 12809846
77. DB Brown WC Chapman RD Cook, et al. 2008 Chemoembolization of hepatocellular carcinoma: patient status at presentation and outcome over 15 years at a single center AJR Am J Roentgenol 190 608 615 10.2214/AJR.07.2879 18287429
78. J Kettenbach A Stadler IV Katzler, et al. 2008 Drug-loaded microspheres for the treatment of liver cancer: review of current results Cardiovasc Intervent Radiol 31 468 476 10.1007/s00270-007-9280-6 18228095